share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(30%),Matthew Friesen(30%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(30%),Matthew Friesen(30%), etc.

Bruush Oral Care | SC 13D/A：超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(30%),Matthew Friesen(30%)等
美股SEC公告 ·  02/10 05:38
牛牛AI助理已提取核心訊息
On February 5, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant change in their holdings of Bruush Oral Care Inc. common shares. The group collectively owns approximately 30% of Bruush Oral Care, which includes 33,000,000 common shares issuable upon the exercise of Pre-Funded Warrants. The Friesens, both Canadian citizens, have joint control over Yaletown Bros. Ventures Ltd and are engaged in investment management. From October 11, 2023, to October 24, 2023, their ownership ranged from 63% to 82% of the company's securities. However, recent transactions have seen the Reporting Persons sell a total of 1,776,986 common shares in the open market. The sales took place between February 5 and February 8, 2024, with prices ranging from $0.1051 to $0.1137 per share. The amendment to Schedule 13D includes a Joint Filing Agreement dated February 9, 2024.
On February 5, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant change in their holdings of Bruush Oral Care Inc. common shares. The group collectively owns approximately 30% of Bruush Oral Care, which includes 33,000,000 common shares issuable upon the exercise of Pre-Funded Warrants. The Friesens, both Canadian citizens, have joint control over Yaletown Bros. Ventures Ltd and are engaged in investment management. From October 11, 2023, to October 24, 2023, their ownership ranged from 63% to 82% of the company's securities. However, recent transactions have seen the Reporting Persons sell a total of 1,776,986 common shares in the open market. The sales took place between February 5 and February 8, 2024, with prices ranging from $0.1051 to $0.1137 per share. The amendment to Schedule 13D includes a Joint Filing Agreement dated February 9, 2024.
2024年2月5日，Yaletown Bros. Ventures Ltd與Matthew Friesen和Bradley Friesen提交了一份Schedule 13D修正案，向美國證券交易委員會報告了其對Bruush Oral Care Inc.普通股持股量的重大變化。該集團共持有Bruush Oral Care約30%的股份，其中包括在行使Pre-Funded Warrants時可發行的3300萬普通股。這兩位加拿大公民的Friesen夫婦共同控制Yaletown Bros. Ventures Ltd，從事投資管理。從2023年10月11日至2023年10月24日，他們的所有權比例從63%到82%。然而，最近的交易使得報告人在公開市場上減持了1776986股普通股。這些銷售發生在2024年2月5日至2月8日期間，股價在0.1051美元至0.1137美元之間。Schedule 13D的修正案包括一個2024年2月9日簽訂的聯合申報協議。
2024年2月5日，Yaletown Bros. Ventures Ltd與Matthew Friesen和Bradley Friesen提交了一份Schedule 13D修正案，向美國證券交易委員會報告了其對Bruush Oral Care Inc.普通股持股量的重大變化。該集團共持有Bruush Oral Care約30%的股份，其中包括在行使Pre-Funded Warrants時可發行的3300萬普通股。這兩位加拿大公民的Friesen夫婦共同控制Yaletown Bros. Ventures Ltd，從事投資管理。從2023年10月11日至2023年10月24日，他們的所有權比例從63%到82%。然而，最近的交易使得報告人在公開市場上減持了1776986股普通股。這些銷售發生在2024年2月5日至2月8日期間，股價在0.1051美元至0.1137美元之間。Schedule 13D的修正案包括一個2024年2月9日簽訂的聯合申報協議。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。